Targeting Allele-Specific Faulty mRNA in SCNA2 Mutation Patients
Targeting Allele-Specific Faulty MRNA In SCNA2 Mutation Patients No comments by: Maya Posch July 23, 2026 Title: Copy Short Link: Copy When an individual is born with genetic defects, there are a few ways to deal with the impact of the faulty genes. The most extreme solution is direct DNA editing to repair the mutation, while the treatment of symptoms with medication is the least invasive, though this comes with its own set of disadvantages. Antisense therapy keeps a middle ground here, by targeting the messenger RNA (mRNA) that forms the bridge between DNA and the translation into a functional protein by the ribosome.
- ▪Targeting Allele-Specific Faulty MRNA In SCNA2 Mutation Patients No comments by: Maya Posch July 23, 2026 Title: Copy Short Link: Copy When an individual is born with genetic defects, there are a few ways to deal with the impact of the faul
- ▪The most extreme solution is direct DNA editing to repair the mutation, while the treatment of symptoms with medication is the least invasive, though this comes with its own set of disadvantages.
- ▪Antisense therapy keeps a middle ground here, by targeting the messenger RNA (mRNA) that forms the bridge between DNA and the translation into a functional protein by the ribosome.
Opening excerpt (first ~120 words) tap to expand
Targeting Allele-Specific Faulty MRNA In SCNA2 Mutation Patients No comments by: Maya Posch July 23, 2026 Title: Copy Short Link: Copy When an individual is born with genetic defects, there are a few ways to deal with the impact of the faulty genes. The most extreme solution is direct DNA editing to repair the mutation, while the treatment of symptoms with medication is the least invasive, though this comes with its own set of disadvantages. Antisense therapy keeps a middle ground here, by targeting the messenger RNA (mRNA) that forms the bridge between DNA and the translation into a functional protein by the ribosome. In a recent study by [Olivia Kim-McManus] et al. antisense therapy with an allele-specific feature was demonstrated in two individuals with SCN2A mutations.
…
Excerpt limited to ~120 words for fair-use compliance. The full article is at Hackaday.
Discussion
0 commentsMore from Hackaday
